ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
76 hedge funds and large institutions have $56.8M invested in Oncternal Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
-8
Holders Change %
-9.52%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
28
Reduced
22
Closed
18
Calls
$1.86M
Puts
$882K
Net Calls
+$975K
Net Calls Change
+$1.72M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$2.2M |
| 2 |
Wells Fargo
San Francisco,
California
|
$1.32M |
| 3 |
Millennium Management
New York
|
$1.33M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
$683K |
| 5 |
Renaissance Technologies
New York
|
$595K |
Top Sellers
| 1 |
Norges Bank
Oslo,
Norway
|
$674K |
| 2 |
ACM
Altium Capital Management
New York
|
$0 |
| 3 |
JGC
J. Goldman & Co
New York
|
$0 |
| 4 |
ACA
Apis Capital Advisors
New York
|
$0 |
| 5 |
Two Sigma Investments
New York
|
$1.89M |
